Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications

IMPORTANCE: Drug safety communications released by the US Food and Drug Administration (FDA) are often based on limited evidence on safety signals after approval. Varenicline may serve as a relevant case study because it was the target of several FDA communications in 2008 and 2009; ultimately, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Ravi J., Good, Meghan M., San-Juan-Rodriguez, Alvaro, Henriksen, Andrew, Cunningham, Francesca, Hernandez, Inmaculada, Good, Chester B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754175/
https://www.ncbi.nlm.nih.gov/pubmed/31483473
http://dx.doi.org/10.1001/jamanetworkopen.2019.10626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754175/
https://www.ncbi.nlm.nih.gov/pubmed/31483473
http://dx.doi.org/10.1001/jamanetworkopen.2019.10626

Ejemplares similares